ScholarIQanswers from OpenAlex

Cost Effectiveness of Molecular Profiling for Adjuvant Decision Making in Patients With Node-Negative Breast Cancer

PaperCitations, authors & open-access status

Cost Effectiveness of Molecular Profiling for Adjuvant Decision Making in Patients With Node-Negative Breast Cancer is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Cost Effectiveness of Molecular Profiling for Adjuvant Decision Making in Patients With Node-Negative Breast Cancer have?

ScholarIQcitation count

Cost Effectiveness of Molecular Profiling for Adjuvant Decision Making in Patients With Node-Negative Breast Cancer has 33 citations in the OpenAlex counts ScholarIQ stores.

When was Cost Effectiveness of Molecular Profiling for Adjuvant Decision Making in Patients With Node-Negative Breast Cancer published?

ScholarIQyear

Cost Effectiveness of Molecular Profiling for Adjuvant Decision Making in Patients With Node-Negative Breast Cancer has 2014 year in the ScholarIQ index.

What is the open-access status of Cost Effectiveness of Molecular Profiling for Adjuvant Decision Making in Patients With Node-Negative Breast Cancer?

ScholarIQoa status

Cost Effectiveness of Molecular Profiling for Adjuvant Decision Making in Patients With Node-Negative Breast Cancer has closed oa status in the ScholarIQ index.

What is the DOI of Cost Effectiveness of Molecular Profiling for Adjuvant Decision Making in Patients With Node-Negative Breast Cancer?

ScholarIQdoi

The DOI for Cost Effectiveness of Molecular Profiling for Adjuvant Decision Making in Patients With Node-Negative Breast Cancer is on the source record.

What is the PMID of Cost Effectiveness of Molecular Profiling for Adjuvant Decision Making in Patients With Node-Negative Breast Cancer?

ScholarIQpmid

The PMID for Cost Effectiveness of Molecular Profiling for Adjuvant Decision Making in Patients With Node-Negative Breast Cancer is on the source record.

What is the OpenAlex record for Cost Effectiveness of Molecular Profiling for Adjuvant Decision Making in Patients With Node-Negative Breast Cancer?

ScholarIQopenalex

The OpenAlex for Cost Effectiveness of Molecular Profiling for Adjuvant Decision Making in Patients With Node-Negative Breast Cancer is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial